Ghoti Ichthus
Genesis 18:32, 2 Chronicles 7:14, Acts 5:29
Well, well, well . . .
Steve Jordahl
May 13, 2024
"Citing low demand, AstraZeneca announced May 8 it is withdrawing the vaccine from the market after supplying about 8 billion doses worldwide, according to a story by The Hill.
AstraZeneca’s vaccine, which was never authorized for use in the U.S., was much more common in poorer countries where a World Health Organization program named COVAX helped distribute it.
The shot was also distributed in Great Britain, where the corporation is headquartered. Great Britain is where more than 50 plaintiffs in a class-action lawsuit are accusing AstraZeneca’s vaccine of causing permanent brain injuries from a blood clot.
As part of that lawsuit, filed in 2023, AstraZeneca has now admitted in court documents the vaccine can, “in very rare cases,” cause blood clots, medically known as Thrombosis with Thrombocytopenia Syndrome, or TTS.
Vaccine critic Dr. Peter McCullough, of the McCullough Foundation, tells AFN the claim about pulling the vaccine due to market demand is not true."
More
McCullough: Don't be fooled over AstraZeneca pulling COVID-19 shot
After a major pharmaceutical company announced it is shelving its COVID-19 vaccine, a well-known critic of the clot-producing shot says don’t believe AstraZeneca’s excuse of waning public demand.Steve Jordahl
May 13, 2024
"Citing low demand, AstraZeneca announced May 8 it is withdrawing the vaccine from the market after supplying about 8 billion doses worldwide, according to a story by The Hill.
AstraZeneca’s vaccine, which was never authorized for use in the U.S., was much more common in poorer countries where a World Health Organization program named COVAX helped distribute it.
The shot was also distributed in Great Britain, where the corporation is headquartered. Great Britain is where more than 50 plaintiffs in a class-action lawsuit are accusing AstraZeneca’s vaccine of causing permanent brain injuries from a blood clot.
As part of that lawsuit, filed in 2023, AstraZeneca has now admitted in court documents the vaccine can, “in very rare cases,” cause blood clots, medically known as Thrombosis with Thrombocytopenia Syndrome, or TTS.
Vaccine critic Dr. Peter McCullough, of the McCullough Foundation, tells AFN the claim about pulling the vaccine due to market demand is not true."
More
McCullough: Don't be fooled over AstraZeneca pulling COVID-19 shot
After a major pharmaceutical company announced it is shelving its COVID-19 vaccine, a well-known critic of the clot-producing shot says don’t believe AstraZeneca’s excuse of waning public demand.
afn.net